CLINICAL_TRIALS
trial_result
· 2015-12-22
Clinical Trial Update: Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 [Phase 3]
Summary
Phase 3 trial update showing goal achievement after using an anti-PCSK9 antibody in statin-intolerant individuals with hyperlipidemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-22